Harvard Bioscience (HBIO)
(Delayed Data from NSDQ)
$3.17 USD
+0.05 (1.60%)
Updated May 31, 2024 04:00 PM ET
After-Market: $3.18 +0.01 (0.32%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Brokerage Reports
0 items in cart
Harvard Bioscience, Inc. [HBIO]
Reports for Purchase
Showing records 41 - 50 ( 50 total )
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
SMALL-CAP SQUAWK
Provider: JGR Capital Partners
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Full year 2013 revenues of $105.2mn were down 5.4% compared to 2012
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Announced financial results for 1Q12
Provider: SEETHRUEQUITY, LLC
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Announced financial results for 4Q11 and FY11
Provider: SEETHRUEQUITY, LLC
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Top-line almost flat on lower organic revenue and rise in inorganic revenue
Provider: SEETHRUEQUITY, LLC
Analyst: RESEARCH D
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Price target revised to $5.41.Update - 2Q11
Provider: SEETHRUEQUITY, LLC
Company: Harvard Bioscience, Inc.
Industry: Instruments - Scientific
Initiating coverage with a price target of $6.05/share
Provider: SEETHRUEQUITY, LLC